Serina Therapeutics's total assets for Q2 2024 were $10.71M, a decrease of -1.36% from the previous quarter. SER total liabilities were $27.10M for the fiscal quarter, a 78.71% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.